Anticancer oncolytic activity of respiratory syncytial virus
- 15 May 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 16 (12), 923-935
- https://doi.org/10.1038/cgt.2009.34
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial VirusOnline Journal of Public Health Informatics, 2008
- BEX2 Is Overexpressed in a Subset of Primary Breast Cancers and Mediates Nerve Growth Factor/Nuclear Factor-κB Inhibition of Apoptosis in Breast Cancer Cell LinesCancer Research, 2007
- Propionyl-L-carnitine Reduces Proliferation and Potentiates Bax-related Apoptosis of Aortic Intimal Smooth Muscle Cells by Modulating Nuclear Factor-κB ActivityOnline Journal of Public Health Informatics, 2007
- VSV-tumor selective replication and protein translationOncogene, 2005
- Apoptosis: mechanisms and relevance in cancerAnnals of Hematology, 2005
- Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance SpectroscopyClinical Cancer Research, 2005
- Use of Replication-Conditional Adenovirus as a Helper System to Enhance Delivery of P450 Prodrug-Activation Genes for Cancer TherapyCancer Research, 2004
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Biochemical Pathways of Caspase Activation During ApoptosisAnnual Review of Cell and Developmental Biology, 1999